Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
P. C. M. Bartels, M. Schoorl, M. Schoorl & M. J. NubÉ. (2003) Deviations in coagulation activation due to treatment with different haemodialysis membranes. Scandinavian Journal of Clinical and Laboratory Investigation 63:6, pages 417-424.
Read now
Read now
P. C. M. Bartels, M. Schoorl, M. Schoorl, J. G. A. Wiering, M. J. Nubé. (2000) Activation of coagulation during treatment with haemodialysis. Scandinavian Journal of Clinical and Laboratory Investigation 60:4, pages 283-290.
Read now
Read now
Articles from other publishers (18)
Anna Wärme, Henrik Hadimeri, Salmir Nasic & Bernd Stegmayr. (2021) The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis. BMC Nephrology 22:1.
Crossref
Crossref
Sarah C. Skinner, Vimal K. Derebail, Caroline J. Poulton, Donna O. Bunch, Prabir Roy-Chaudhury & Nigel S. Key. (2021) Hemodialysis-Related Complement and Contact Pathway Activation and Cardiovascular Risk: A Narrative Review. Kidney Medicine 3:4, pages 607-618.
Crossref
Crossref
Fabian Obstals, Lena Witzdam, Manuela Garay-Sarmiento, Nina Yu. Kostina, Jonas Quandt, Rolf Rossaint, Smriti Singh, Oliver Grottke & Cesar Rodriguez-Emmenegger. (2021) Improving Hemocompatibility: How Can Smart Surfaces Direct Blood To Fight against Thrombi. ACS Applied Materials & Interfaces 13:10, pages 11696-11707.
Crossref
Crossref
Simon J. Middendorp, Jonas Wilbs, Claudia Quarroz, Sara Calzavarini, Anne Angelillo-Scherrer & Christian Heinis. (2017) Peptide Macrocycle Inhibitor of Coagulation Factor XII with Subnanomolar Affinity and High Target Selectivity. Journal of Medicinal Chemistry 60:3, pages 1151-1158.
Crossref
Crossref
Linda Labberton, Ellinor Kenne, Andy T. Long, Katrin F. Nickel, Antonio Di Gennaro, Rachel A. Rigg, James S. Hernandez, Lynn Butler, Coen Maas, Evi X. Stavrou & Thomas Renné. (2016) Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection. Nature Communications 7:1.
Crossref
Crossref
E. Kenne, K. F. Nickel, A. T. Long, T. A. Fuchs, E. X. Stavrou, F. R. Stahl & T. Renné. (2015) Factor XII: a novel target for safe prevention of thrombosis and inflammation. Journal of Internal Medicine 278:6, pages 571-585.
Crossref
Crossref
L. Labberton, E. Kenne & T. Renné. (2017) New agents for thromboprotection. Hämostaseologie 35:04, pages 338-350.
Crossref
Crossref
Tobias Kyrk, Alex Bechara, Malin Skagerlind & Bernd Stegmayr. (2014)
Heparin and Albumin as Part of the Priming Solution Limits Exposure to Anticoagulation during Hemodialysis:
In Vitro
Studies
. The International Journal of Artificial Organs 37:10, pages 734-740.
Crossref
Crossref
Ellinor Kenne & Thomas Renné. (2014) Factor XII: a drug target for safe interference with thrombosis and inflammation. Drug Discovery Today 19:9, pages 1459-1464.
Crossref
Crossref
Bernd G. Stegmayr, Per Jonsson & Dana Mahmood. (2013) A Significant Proportion of Patients Treated with Citrate Containing Dialysate Need Additional Anticoagulation. The International Journal of Artificial Organs 36:1, pages 1-6.
Crossref
Crossref
U. Forsberg, P. Jonsson, C. Stegmayr & B. Stegmayr. (2010) Microemboli, developed during haemodialysis, pass the lung barrier and may cause ischaemic lesions in organs such as the brain. Nephrology Dialysis Transplantation 25:8, pages 2691-2695.
Crossref
Crossref
Kaushik Chatterjee, Jennifer L. Thornton, James W. Bauer, Erwin A. Vogler & Christopher A. Siedlecki. (2009) Moderation of prekallkrein–factor XII interactions in surface activation of coagulation by protein-adsorption competition. Biomaterials 30:28, pages 4915-4920.
Crossref
Crossref
Peter C. Papageorgiou, Demetrios Simos, Frans Boomsma, Rasmus Rojkjaer & Daniel H. Osmond. (2009) Angiotensin converting enzyme-regulated, noncholinergic sympathoadrenal catecholamine release mediates the cardiovascular actions of human ‘new pressor protein’ related to coagulation beta-factor XIIa. Canadian Journal of Cardiology 25:4, pages e100-e108.
Crossref
Crossref
Bernd Stegmayr, Ulf Forsberg, Per Jonsson & Christofer Stegmayr. (2007) The Sensor in the Venous Chamber Does Not Prevent Passage of Air Bubbles During Hemodialysis. Artificial Organs 31:2, pages 162-166.
Crossref
Crossref
Per Jonsson, Lars Karlsson, Ulf Forsberg, Margareta Gref, Christofer Stegmayr & Bernd Stegmayr. (2007) Air Bubbles Pass the Security System of the Dialysis Device Without Alarming. Artificial Organs 31:2, pages 132-139.
Crossref
Crossref
Peter C. Papageorgiou, Ali Pourdjabbar, Akis A. Amfilochiadis, Eleftherios P. Diamandis, Frans Boomsma & Daniel H. Osmond. (2004) Are cardiovascular and sympathoadrenal effects of human “new pressor protein” preparations attributable to human coagulation β-FXIIa?. American Journal of Physiology-Heart and Circulatory Physiology 286:3, pages H837-H846.
Crossref
Crossref
Bernd G. Stegmayr, Ravjet Banga, Lars Berggren, Rut Norda, Anders Rydvall & Tomas Vikerfors. (2003) Plasma exchange as rescue therapy in multiple organ failure including acute renal failure*. Critical Care Medicine 31:6, pages 1730-1736.
Crossref
Crossref
Rolf Dario Frank, Jürgen Weber, Heike Dresbach, Herbert Thelen, Claudia Weiss & Jürgen Floege. (2001) Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney International 60:5, pages 1972-1981.
Crossref
Crossref